{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T09:27:53Z","timestamp":1749461273735},"reference-count":29,"publisher":"Codon Publications","issue":"1","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Allergologia et Immunopathologia"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.aller.2016.04.014","type":"journal-article","created":{"date-parts":[[2016,7,30]],"date-time":"2016-07-30T09:29:36Z","timestamp":1469870976000},"page":"55-62","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Prospective evaluation of Streptococcus pneumoniae serum antibodies in patients with primary immunodeficiency on regular intravenous immunoglobulin treatment"],"prefix":"10.15586","volume":"45","author":[{"given":"R.M.","family":"Sim\u00e3o-Gurge","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.T.","family":"Costa-Carvalho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.A.","family":"Nobre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.G.S.","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.I.","family":"de Moraes-Pinto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"6228","reference":[{"key":"10.1016\/j.aller.2016.04.014_bib0150","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1128\/CMR.00001-09","article-title":"Pathogenesis, diagnosis, and management of primary antibody deficiencies and infections","volume":"22","author":"Fried","year":"2009","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.aller.2016.04.014_bib0155","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1067\/mai.2002.124999","article-title":"Efficacy of intravenous immunoglobulin in the prevention of pneumonia in patients with common variable immunodeficiency","volume":"109","author":"Busse","year":"2002","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.aller.2016.04.014_bib0160","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1086\/587669","article-title":"Infections in 252 patients with common variable immunodeficiency","volume":"46","author":"Oksenhendler","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.aller.2016.04.014_bib0165","doi-asserted-by":"crossref","first-page":"3816","DOI":"10.1016\/j.vaccine.2007.01.119","article-title":"Estimating the protective concentration of anti-pneumococcal capsular polysaccharide antibodies","volume":"25","author":"Siber","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.aller.2016.04.014_bib0170","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/(SICI)1099-0496(199609)22:3<167::AID-PPUL5>3.0.CO;2-M","article-title":"Post-immunization pneumococcal antibody titers and IgG subclasses","volume":"22","author":"Sorensen","year":"1996","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.aller.2016.04.014_bib0175","first-page":"1","article-title":"The immunological basis for immunization series: module 12: pneumococcal vaccines","volume":"12","author":"K\u00e4yhty","year":"2009","journal-title":"Immun Vaccines Biol"},{"key":"10.1016\/j.aller.2016.04.014_bib0180","first-page":"239","article-title":"The efficacy of immunoglobulin replacement therapy in the long-term follow-up of the B-cell deficiencies (XLA, HIM, CVID)","volume":"47","author":"Bayrakci","year":"2005","journal-title":"Turk J Pediatr"},{"key":"10.1016\/j.aller.2016.04.014_bib0185","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.jaci.2006.01.015","article-title":"Use of intravenous immunoglobulin in human disease: a review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy Asthma and Immunology","volume":"117","author":"Orange","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.aller.2016.04.014_bib0190","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1093\/infdis\/166.1.38","article-title":"IgG antibody reactive with five serotypes of Streptococcus pneumoniae in commercial intravenous immunoglobulin preparations","volume":"166","author":"Hamill","year":"1991","journal-title":"J Infect Dis"},{"key":"10.1016\/j.aller.2016.04.014_bib0195","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.jaci.2007.11.001","article-title":"Consistency of protective antibody levels across lots of intravenous immunoglobulin preparations","volume":"121","author":"Lejtenyi","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.aller.2016.04.014_bib0200","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/cei.12665","article-title":"Streptococcus pneumoniae antibody titres in patients with primary antibody deficiency receiving intravenous immunoglobulin (IVIG) compared to subcutaneous immunoglobulin (SCIG)","volume":"182","author":"Knutsen","year":"2015","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.aller.2016.04.014_bib0205","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1016\/j.jaci.2008.12.065","article-title":"Quantitation of antibodies in the sera of immunodeficient patients receiving monthly intravenous immune globulin (IVIg)","volume":"123","author":"Pieretti","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.aller.2016.04.014_bib0210","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S0022-3476(99)70246-5","article-title":"Early and prolonged intravenous immunoglobulin replacement therapy in childhood agammaglobulinemia: a retrospective survey of 31 patients","volume":"134","author":"Quartier","year":"1999","journal-title":"J Pediatr"},{"key":"10.1016\/j.aller.2016.04.014_bib0215","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1128\/CDLI.11.6.1158-1164.2004","article-title":"Characterization of antibodies to capsular polysaccharide antigens of Haemophilus influenzae type b and Streptococcus pneumoniae in human immune globulin intravenous preparations","volume":"11","author":"Mikolajczyk","year":"2004","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.aller.2016.04.014_bib0220","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1136\/jcp.55.8.577","article-title":"Survey of infection in patients receiving antibody replacement treatment for immune deficiency","volume":"55","author":"Pettit","year":"2002","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.aller.2016.04.014_bib0225","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1086\/587669","article-title":"Infections in 252 patients with common variable immunodeficiency","volume":"46","author":"Oksenhendler","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.aller.2016.04.014_bib0230","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1097\/INF.0b013e31825c4b7e","article-title":"Frequency and clinical outcome of respiratory viral infections and mixed viral-bacterial infections in children with cancer, fever and neutropenia","volume":"31","author":"Torres","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.aller.2016.04.014_bib0235","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1183\/09031936.00081409","article-title":"Infection as a comorbidity of COPD","volume":"35","author":"Sethi","year":"2010","journal-title":"Eur Respir J"},{"key":"10.1016\/j.aller.2016.04.014_bib0240","doi-asserted-by":"crossref","first-page":"e154","DOI":"10.1542\/peds.2013-1155","article-title":"Pneumococcal antibody levels in children with PID receiving immunoglobulin","volume":"133","author":"Tuerlinckx","year":"2014","journal-title":"Pediatrics"},{"key":"10.1016\/j.aller.2016.04.014_bib0245","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jaci.2013.12.1077","article-title":"Clinical picture and treatment of 2212 patients with common variable immunodeficiency","volume":"134","author":"Gathmann","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.aller.2016.04.014_bib0250","series-title":"Informe Regional de SIREVA II, 2011: datos por pa\u00eds y por grupos de edad sobre las caracter\u00edsticas de los aislamientos de Streptococcus pneumoniae, Haemophilus influenzae y Neisseria meningitidis en procesos invasores","author":"Organizaci\u00f3n Panamericana de la Salud","year":"2012"},{"key":"10.1016\/j.aller.2016.04.014_bib0255","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.iac.2008.06.006","article-title":"Pharmacokinetics of immunoglobulin administered via intravenous or subcutaneous routes","volume":"28","author":"Bonilla","year":"2008","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.aller.2016.04.014_bib0260","first-page":"11","article-title":"Intravenous immune globulins: therapeutic, pharmaceutical, & cost considerations","volume":"28","author":"Siegel","year":"2001","journal-title":"Pharm Pract"},{"key":"10.1016\/j.aller.2016.04.014_bib0265","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.clim.2009.10.003","article-title":"Use of intravenous immunoglobulin and adjunctive therapies in the treatment of primary immunodeficiencies: a working group report of and study by the Primary Immunodeficiency Committee of the American Academy of Allergy Asthma and Immunology","volume":"135","author":"Yong","year":"2010","journal-title":"Clin Immunol"},{"key":"10.1016\/j.aller.2016.04.014_bib0270","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.clim.2010.06.012","article-title":"Impact of trough IgG on pneumonia incidence in primary immunodeficiency: a meta-analysis of clinical studies","volume":"137","author":"Orange","year":"2010","journal-title":"Clin Immunol"},{"key":"10.1016\/j.aller.2016.04.014_bib0275","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1471-2466-12-37","article-title":"Reduced rhinovirus-specific antibodies are associated with acute exacerbations of chronic obstructive pulmonary disease requiring hospitalisation","volume":"12","author":"Yerkovich","year":"2012","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.aller.2016.04.014_bib0280","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1016\/j.jaci.2011.01.035","article-title":"Pathogen-specific IgG antibody levels in patients receiving immunoglobulin replacement do not provide additional benefit to therapeutic management over total serum IgG","volume":"127","author":"Chua","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.aller.2016.04.014_bib0285","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1590\/S0036-46652015000500017","article-title":"Protective levels of Varicella-Zoster antibody did not effectively prevent chickenpox in an X-linked agammaglobulinemia patient","volume":"57","author":"Nobre","year":"2015","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"10.1016\/j.aller.2016.04.014_bib0290","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1471-2172-15-26","article-title":"Antibody levels to tetanus, diphtheria, measles and varicella in patients with primary immunodeficiency undergoing intravenous immunoglobulin therapy: a prospective study","volume":"15","author":"Nobre","year":"2014","journal-title":"BMC Immunol"}],"container-title":["Allergologia et Immunopathologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301054616300763?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301054616300763?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,12,31]],"date-time":"2020-12-31T22:50:49Z","timestamp":1609455049000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301054616300763"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["S0301054616300763"],"URL":"https:\/\/doi.org\/10.1016\/j.aller.2016.04.014","relation":{},"ISSN":["0301-0546"],"issn-type":[{"value":"0301-0546","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prospective evaluation of Streptococcus pneumoniae serum antibodies in patients with primary immunodeficiency on regular intravenous immunoglobulin treatment","name":"articletitle","label":"Article Title"},{"value":"Allergologia et Immunopathologia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aller.2016.04.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 SEICAP. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}